Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03920839 |
| Title | INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105) |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Incyte Corporation |
| Indications | |
| Therapies |
Carboplatin + Paclitaxel + Retifanlimab Cisplatin + Gemcitabine + Retifanlimab |
| Age Groups: | adult | senior |
| Covered Countries |
| Facility | Status | City | State | Zip | Country | Details |
|---|